{"id":407210,"date":"2021-01-04T06:13:25","date_gmt":"2021-01-04T11:13:25","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=407210"},"modified":"2021-01-04T06:13:25","modified_gmt":"2021-01-04T11:13:25","slug":"zomedica-appoints-robert-cohen-ceo-as-company-nears-commercialization-of-truforma","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/zomedica-appoints-robert-cohen-ceo-as-company-nears-commercialization-of-truforma\/","title":{"rendered":"Zomedica Appoints Robert Cohen CEO as Company Nears Commercialization of TRUFORMA\u2122"},"content":{"rendered":"
\n

ANN ARBOR, Mich., Jan. 04, 2021 (GLOBE NEWSWIRE) — Zomedica Corp. (NYSE American: ZOM) (\u201cZomedica\u201d or the \u201cCompany\u201d), a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced the appointment of Robert Cohen as Chief Executive Officer effective January 1, 2021. Mr. Cohen previously served as the Company\u2019s Interim CEO and as a member of the Board of Directors.<\/p>\n

Mr. Cohen\u00a0brings to Zomedica more than 30 years of executive leadership and operations experience from the medical device, biotechnology and pharmaceutical industries.\u00a0Following his earlier tenure at three multi-billion-dollar medical technology companies, Mr. Cohen built shareholder value at a series of smaller organizations as Chief Executive Officer. The Board of Directors recruited\u00a0Mr. Cohen due to his successful track record in building early-stage companies and developing and launching a series of medical devices and biotechnology products. Mr. Cohen\u00a0will continue to drive the completion of the development and commercialization of the Company\u2019s TRUFORMA\u2122\u00a0point-of-care diagnostic platform.<\/p>\n

Mr.\u00a0Jeffrey Rowe, Chairman of the Board, commented, \u201cOver the past six months we have enjoyed collaborating with Rob and have been thoroughly impressed with his business acumen and the professional leadership skills he has brought to Zomedica at such a crucial time. The Board is excited that\u00a0Rob has agreed to accept the CEO position as we near our most pivotal milestone. Rob\u2019s successful track record in launching medical devices is perfectly aligned for Zomedica\u2019s needs as we complete the development of our TRUFORMA\u2122 platform and achieve its commercial launch.\u00a0The Board and our employees remain excited about the near-term launch, our commercialization strategy, and Zomedica\u2019s longer-term growth opportunity.\u201d\u00a0\u00a0<\/p>\n

\u201cI am honored to move into the CEO role at this most pivotal time,\u201d commented Robert Cohen, Chief Executive Officer of Zomedica. \u201cSince I initially joined the Company this past June, I have had time to appreciate the strong capabilities of not only our Board of Directors, but also the entire Zomedica team, and I proudly can say that I believe that we are strongly positioned to capitalize on our commercial launch. The industry dynamics are extremely exciting, and we believe that the large addressable diagnostic market opportunity lends itself perfectly to our TRUFORMA\u2122\u00a0point-of-care diagnostic platform.\u201d<\/p>\n

\n About Zomedica<\/strong>
\n
Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for dogs and cats by focusing on the unmet needs of clinical veterinarians. Zomedica\u2019s product portfolio will include innovative diagnostics and medical devices that emphasize patient health and practice health. It is Zomedica\u2019s mission to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit www.ZOMEDICA.com<\/a>.<\/p>\n

\n Follow Zomedica<\/strong>\n <\/p>\n